| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8535082 | Life Sciences | 2018 | 23 Pages |
Abstract
RPA1 serves as an oncogene during gastrointestinal cancers progression. These studies reveal a new target for gastrointestinal cancers therapy, and the combination of 5-Fu and silencing of RPA1 provides a new attractive therapeutic measure for gastrointestinal cancers.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Zhu Yuesheng, Yi Yongdong, Bai Binglong, Li Liyi, You Tao, Sun Weijian, Yu Yaojun,